Arizona legislators on Tuesday will review Attorney General Tom Horne's plan for use of the state's $6 million share of a multistate settlement with the drug company Johnson & Johnson.

The Joint Legislative Budget Committee will review Horne's plan to use $2 million of the settlement share for consumer fraud investigations and related consumer education.

Horne has proposed that an additional $4 million be used for research and programs related to mental illness, dementia and developmental and learning disorders.

The settlement with Johnson & Johnson subsidiary Janssen Pharmaceuticals Inc. stems from marketing of anti-psychotic drugs.

A complaint alleged that the company engaged in unfair and deceptive practices when it marketed Risperdal for unapproved uses.